首页 > 最新文献

Cardiology journal最新文献

英文 中文
Comparisons of three-year outcomes according to the degree of left ventricular ejection fraction in patients with myocardial infarction with non-ST-segment elevation with and without chronic kidney disease. 非st段抬高心肌梗死伴和不伴慢性肾脏疾病患者左室射血分数程度的三年预后比较
Pub Date : 2025-12-15 DOI: 10.5603/cj.103619
Yong Hoon Kim, Ae-Young Her, Seung-Woon Rha, Cheol Ung Choi, Byoung Geol Choi, Soohyung Park, Su Jin Hyun, Jung Rae Cho, Min-Woong Kim, Ji-Young Park, Myung Ho Jeong

Background: Because renal and cardiac function are key to the prognosis of patients with coronary artery disease, we compared three-year clinical outcomes based on the degree of left ventricular ejection fraction (LVEF) in patients with non-ST-segment elevation myocardial infarction (NSTEMI) with or without chronic kidney disease (CKD) METHODS: A total of 4567 patients diagnosed with NSTEMI were enrolled and stratified into CKD (1270 patients) and non-CKD (3297 patients) groups. Each group was further classified into heart failure (HF) with reduced EF (HFrEF), HF with mildly reduced EF (HFmrEF), and HF with preserved EF (HFpEF) subgroups. The primary outcome was all-cause death.

Results: In both the CKD and non-CKD groups, the adjusted rates of all-cause death (both p < 0.001) and cardiac death (CD, both p < 0.001) in the HFrEF subgroup were significantly higher than in the HFmrEF and HFpEF subgroups. However, within the CKD group, the all-cause death rate was comparable between the HFmrEF and HFpEF subgroups. In contrast, within the non-CKD group, the rates of all-cause death (p = 0.005) and CD (p = 0.008) were significantly higher in the HFmrEF subgroup compared to the HFpEF subgroup. The increased all-cause death in the CKD group, relative to the non-CKD group, within the HFpEF subgroup contributed to these outcomes.

Conclusions: Regardless of CKD status, the HFrEF subgroup showed higher mortality rates compared with the HFmrEF and HFpEF subgroups. However, the mortality rate differed between the HFmrEF and the HFpEF subgroups in both the CKD and the non-CKD groups.

背景:由于肾功能和心功能是冠状动脉疾病患者预后的关键,我们比较了伴有或不伴有慢性肾脏疾病(CKD)的非st段抬高型心肌梗死(NSTEMI)患者3年的临床结果,基于左心室射血分数(LVEF)的程度。方法:共入组4567例诊断为NSTEMI的患者,并将其分为CKD组(1270例)和非CKD组(3297例)。各组进一步分为心力衰竭(HF)伴心力衰竭(HFrEF)、心力衰竭伴心力衰竭(HFmrEF)和心力衰竭伴心力衰竭(HFpEF)亚组。主要结局是全因死亡。结果:在CKD和非CKD组中,HFrEF亚组的调整后全因死亡率(p < 0.001)和心源性死亡率(CD, p < 0.001)均显著高于HFmrEF和HFpEF亚组。然而,在CKD组中,HFmrEF和HFpEF亚组之间的全因死亡率是相当的。相比之下,在非ckd组中,HFmrEF亚组的全因死亡率(p = 0.005)和CD (p = 0.008)明显高于HFpEF亚组。与非CKD组相比,HFpEF亚组中CKD组全因死亡率的增加促成了这些结果。结论:无论CKD状态如何,与HFmrEF和HFpEF亚组相比,HFrEF亚组的死亡率更高。然而,在CKD组和非CKD组中,HFmrEF和HFpEF亚组的死亡率不同。
{"title":"Comparisons of three-year outcomes according to the degree of left ventricular ejection fraction in patients with myocardial infarction with non-ST-segment elevation with and without chronic kidney disease.","authors":"Yong Hoon Kim, Ae-Young Her, Seung-Woon Rha, Cheol Ung Choi, Byoung Geol Choi, Soohyung Park, Su Jin Hyun, Jung Rae Cho, Min-Woong Kim, Ji-Young Park, Myung Ho Jeong","doi":"10.5603/cj.103619","DOIUrl":"https://doi.org/10.5603/cj.103619","url":null,"abstract":"<p><strong>Background: </strong>Because renal and cardiac function are key to the prognosis of patients with coronary artery disease, we compared three-year clinical outcomes based on the degree of left ventricular ejection fraction (LVEF) in patients with non-ST-segment elevation myocardial infarction (NSTEMI) with or without chronic kidney disease (CKD) METHODS: A total of 4567 patients diagnosed with NSTEMI were enrolled and stratified into CKD (1270 patients) and non-CKD (3297 patients) groups. Each group was further classified into heart failure (HF) with reduced EF (HFrEF), HF with mildly reduced EF (HFmrEF), and HF with preserved EF (HFpEF) subgroups. The primary outcome was all-cause death.</p><p><strong>Results: </strong>In both the CKD and non-CKD groups, the adjusted rates of all-cause death (both p < 0.001) and cardiac death (CD, both p < 0.001) in the HFrEF subgroup were significantly higher than in the HFmrEF and HFpEF subgroups. However, within the CKD group, the all-cause death rate was comparable between the HFmrEF and HFpEF subgroups. In contrast, within the non-CKD group, the rates of all-cause death (p = 0.005) and CD (p = 0.008) were significantly higher in the HFmrEF subgroup compared to the HFpEF subgroup. The increased all-cause death in the CKD group, relative to the non-CKD group, within the HFpEF subgroup contributed to these outcomes.</p><p><strong>Conclusions: </strong>Regardless of CKD status, the HFrEF subgroup showed higher mortality rates compared with the HFmrEF and HFpEF subgroups. However, the mortality rate differed between the HFmrEF and the HFpEF subgroups in both the CKD and the non-CKD groups.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technologies in minimally invasive treatment of severe mitral regurgitation. 严重二尖瓣反流的微创治疗技术。
Pub Date : 2025-12-08 DOI: 10.5603/cj.103296
Magdalena Synak, Marta Mazur, Kamil Marzec, Krzysztof Sanetra, Justyna Jankowska-Sanetra, Piotr P Buszman, Paweł Kaźmierczak, Krzysztof Milewski, Witold Gerber

Mitral valve regurgitation is the second most common valve defect in Europe among adults. Primary mitral regurgitation (MR) results from structural abnormalities of the valve apparatus (e.g., leaflet prolapse, chordae rupture), often due to myxomatous degeneration or congenital defects. Secondary MR arises from left ventricular remodeling (e.g., after myocardial infarction or heart failure), leading to functional valve incompetence despite normal valve structure. The choice of treatment depends on the degree of valve regurgitation and the severity of the patient's clinical symptoms. The focus herein is on discussing the anatomy of the mitral valve, the pathophysiology of regurgitation, and diagnostic methods. The qualification process is then outlined for invasive treatment and various methods of mitral valve repair, including new minimally invasive techniques. Transcatheter mitral valve repair methods are discussed, among other methods, "edge-to-edge" repair and transcatheter mitral valve replacement. Publicly available data confirms that the latter is a widely available and safe treatment method, that represents a promising alternative to surgical treatment.

二尖瓣反流是欧洲成年人中第二常见的瓣膜缺损。原发性二尖瓣反流(MR)是由瓣膜结构异常(如小叶脱垂、索断裂)引起的,通常是由于粘液瘤变性或先天性缺陷。继发性MR发生于左心室重构(如心肌梗死或心力衰竭后),导致瓣膜功能不全,尽管瓣膜结构正常。治疗的选择取决于瓣膜返流的程度和患者临床症状的严重程度。本文的重点是讨论二尖瓣的解剖、反流的病理生理和诊断方法。然后概述了侵入性治疗和各种二尖瓣修复方法的鉴定过程,包括新的微创技术。讨论了经导管二尖瓣修复方法,其中包括“边缘到边缘”修复和经导管二尖瓣置换术。可公开获得的数据证实,后者是一种广泛可用且安全的治疗方法,代表了手术治疗的一种有希望的替代方法。
{"title":"Technologies in minimally invasive treatment of severe mitral regurgitation.","authors":"Magdalena Synak, Marta Mazur, Kamil Marzec, Krzysztof Sanetra, Justyna Jankowska-Sanetra, Piotr P Buszman, Paweł Kaźmierczak, Krzysztof Milewski, Witold Gerber","doi":"10.5603/cj.103296","DOIUrl":"10.5603/cj.103296","url":null,"abstract":"<p><p>Mitral valve regurgitation is the second most common valve defect in Europe among adults. Primary mitral regurgitation (MR) results from structural abnormalities of the valve apparatus (e.g., leaflet prolapse, chordae rupture), often due to myxomatous degeneration or congenital defects. Secondary MR arises from left ventricular remodeling (e.g., after myocardial infarction or heart failure), leading to functional valve incompetence despite normal valve structure. The choice of treatment depends on the degree of valve regurgitation and the severity of the patient's clinical symptoms. The focus herein is on discussing the anatomy of the mitral valve, the pathophysiology of regurgitation, and diagnostic methods. The qualification process is then outlined for invasive treatment and various methods of mitral valve repair, including new minimally invasive techniques. Transcatheter mitral valve repair methods are discussed, among other methods, \"edge-to-edge\" repair and transcatheter mitral valve replacement. Publicly available data confirms that the latter is a widely available and safe treatment method, that represents a promising alternative to surgical treatment.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145679552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Domain-specific knowledge on salt-related health risks and medical professional identity: Implications for cardi-ovascular prevention. 关于盐相关健康风险和医学专业身份的特定领域知识:对心血管疾病预防的影响
Pub Date : 2025-12-05 DOI: 10.5603/cj.108977
Stanisław Surma, Łukasz Lewandowski, Karol Momot, Michał Czapla, Tomasz Sobierajski, Joanna Lewek, Bogusław Okopień, Maciej Banach

Background: Excessive salt consumption is one of the most important and modifiable risk factors for cardiovascular disease (CVD). Despite general awareness of its cardiovascular impact, knowledge about other health consequences of excess sodium varies considerably, even among medical professionals. This study was conducted to examine whether domain-specific knowledge about salt-related health effects is predictive of professional affiliation with the medical community (medical education/degree) and explored its implications for cardiovascular prevention.

Methods: An international online survey (PoLA/ILEP) of 668 adults was conducted using the CAWI method. The questionnaire included 17 items assessing knowledge in five domains - cardiovascular, metabolic, renal, neuropsychiatric, and bone health - as well as awareness of dietary salt sources and self-monitoring of personal health parameters. Associations between domain-specific knowledge and medical education were analyzed using proportional odds logistic regression (POLR), adjusting for age, sex, place of residence, and number of cardiovascular risk factors.

Results: Knowledge of cardiovascular and neuropsychiatric consequences was strongly associated with medical education (OR 21.7 and 1.66; p < 0.05). In contrast, a better understanding of metabolic, renal, and bone effects was linked with lower odds of medical education (OR 0.28-0.54). The strongest predictor was self-awareness of personal cardiovascular parameters (OR = 37.97; p < 0.0001). Among rural residents, these relationships were particularly pronounced.

Conclusions: Medical professional identity is associated with structured, domain-specific knowledge about the health effects of salt consumption, particularly in relation to CVD. Expanding educational efforts to address under-recognized consequences of sodium excess may improve salt-reduction strategies and enhance cardiovascular disease prevention.

背景:盐摄入过多是心血管疾病(CVD)最重要且可改变的危险因素之一。尽管人们普遍意识到钠对心血管的影响,但即使在医疗专业人员中,对过量钠对其他健康后果的了解也存在很大差异。本研究旨在探讨有关盐相关健康影响的特定领域知识是否可预测与医学界的专业关系(医学教育/学位),并探讨其对心血管预防的影响。方法:采用CAWI方法对668名成人进行国际在线调查(PoLA/ILEP)。问卷包括17个项目,评估五个领域的知识——心血管、代谢、肾脏、神经精神和骨骼健康——以及对饮食盐来源的认识和个人健康参数的自我监测。在调整了年龄、性别、居住地和心血管危险因素后,采用比例logistic回归(POLR)分析了特定领域知识与医学教育之间的关系。结果:心血管和神经精神后果知识与医学教育程度密切相关(OR分别为21.7和1.66;p < 0.05)。相比之下,更好地了解代谢、肾脏和骨骼影响与较低的医学教育几率相关(OR 0.28-0.54)。最有力的预测因子是个人心血管参数的自我意识(OR = 37.97; p < 0.0001)。在农村居民中,这种关系尤为明显。结论:医学专业认同与结构化的、特定领域的关于盐摄入对健康影响的知识相关,特别是与心血管疾病相关的知识。扩大教育工作以解决未被充分认识到的钠过量后果,可能会改善减盐策略并加强心血管疾病的预防。
{"title":"Domain-specific knowledge on salt-related health risks and medical professional identity: Implications for cardi-ovascular prevention.","authors":"Stanisław Surma, Łukasz Lewandowski, Karol Momot, Michał Czapla, Tomasz Sobierajski, Joanna Lewek, Bogusław Okopień, Maciej Banach","doi":"10.5603/cj.108977","DOIUrl":"https://doi.org/10.5603/cj.108977","url":null,"abstract":"<p><strong>Background: </strong>Excessive salt consumption is one of the most important and modifiable risk factors for cardiovascular disease (CVD). Despite general awareness of its cardiovascular impact, knowledge about other health consequences of excess sodium varies considerably, even among medical professionals. This study was conducted to examine whether domain-specific knowledge about salt-related health effects is predictive of professional affiliation with the medical community (medical education/degree) and explored its implications for cardiovascular prevention.</p><p><strong>Methods: </strong>An international online survey (PoLA/ILEP) of 668 adults was conducted using the CAWI method. The questionnaire included 17 items assessing knowledge in five domains - cardiovascular, metabolic, renal, neuropsychiatric, and bone health - as well as awareness of dietary salt sources and self-monitoring of personal health parameters. Associations between domain-specific knowledge and medical education were analyzed using proportional odds logistic regression (POLR), adjusting for age, sex, place of residence, and number of cardiovascular risk factors.</p><p><strong>Results: </strong>Knowledge of cardiovascular and neuropsychiatric consequences was strongly associated with medical education (OR 21.7 and 1.66; p < 0.05). In contrast, a better understanding of metabolic, renal, and bone effects was linked with lower odds of medical education (OR 0.28-0.54). The strongest predictor was self-awareness of personal cardiovascular parameters (OR = 37.97; p < 0.0001). Among rural residents, these relationships were particularly pronounced.</p><p><strong>Conclusions: </strong>Medical professional identity is associated with structured, domain-specific knowledge about the health effects of salt consumption, particularly in relation to CVD. Expanding educational efforts to address under-recognized consequences of sodium excess may improve salt-reduction strategies and enhance cardiovascular disease prevention.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145679525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic performance of angiography-derived IMR for coronary microcirculation disease assessment in INOCA patients. 血管造影衍生的IMR对冠心病患者冠状动脉微循环疾病评估的诊断价值。
Pub Date : 2025-11-25 DOI: 10.5603/cj.106088
Marta Diachyshyn, Łukasz Niewiara, Piotr Szolc, Paweł Kleczyński, Paulina Judziało, Bartłomiej Guzik, Krzysztof Żmudka, Jacek Legutko

Background: Diagnosis of coronary microcirculatory dysfunction with wire-based methodology imposes a risk of unplanned revascularization in patients with ischemia and no obstructive coronary arteries (INOCA). Non-invasive, angiography-based methods are introduced to alleviate this risk. The angiography-based index of microcirculatory resistance (IMRangio) is a computational fluid dynamics (CFD)-based index utilizing high-quality angiography and aortic pressures to calculate a surrogate of the index of microcirculatory resistance (IMR).

Aim of the study: This study aims to assess the correlation between IMRangio and invasive thermodilution-based IMR in INOCA patients qualified to the MOSAIC-COR registry.

Methods: Data from 74 patients (92 coronaries including 52 left anterior descending arteries) from the MOSAIC-COR registry were used for this sub-analysis. All patients had undergone complex coronary physiology assessment using a thermistor-equipped wire and thermodilution-based methodology with subsequent vasomotor acetylcholine vasospasm testing. Post-hoc, CFD-based angiogram analysis was performed to calculate IMRangio values.

Results: The median age of patients was 64 years, and 59.3% were female. The median calculated value of IMRangio was 29 (Q1-Q3: 22-46), whereas the invasively measured IMR median value was 17 (Q1-Q3: 13-26). A significant correlation between IMRangio and invasive-IMR was observed (Spearman rho 0.29, < 0.001). Angiography based index of microcirculatory resistance area under the curve (AUC) was 62.2, and a value > 46.5 U was identified as the best cut-off for prediction of IMR > 25 and provided 38% sensitivity and 82% specificity to detect coronary microcirculatory dysfunction (CMD).

Conclusion: S: The angiography-based index of microcirculatory resistance significantly correlates with invasively measured IMR; however, a higher cut-off value should be considered to improve the specificity of the method to detect CMD.

背景:在没有冠状动脉梗阻(INOCA)的缺血患者中,用金属丝法诊断冠状动脉微循环功能障碍会增加意外血运重建的风险。非侵入性的血管造影方法被引入以减轻这种风险。基于血管造影的微循环阻力指数(IMRangio)是一种基于计算流体动力学(CFD)的指数,利用高质量的血管造影和主动脉压力来计算微循环阻力指数(IMR)的替代品。研究目的:本研究旨在评估符合MOSAIC-COR登记标准的INOCA患者的IMRangio和基于侵入性热调节的IMR之间的相关性。方法:采用MOSAIC-COR登记的74例患者(92条冠状动脉,包括52条左前降支)的数据进行亚分析。所有患者均接受了复杂的冠状动脉生理学评估,使用配备热敏电阻的导线和基于热调节的方法,随后进行血管舒张性乙酰胆碱血管痉挛测试。事后,基于cfd的血管造影分析计算IMRangio值。结果:患者中位年龄64岁,女性占59.3%。IMRangio计算值中位数为29 (Q1-Q3: 22-46),有创测量IMR中位数为17 (Q1-Q3: 13-26)。IMRangio与侵袭性imr之间存在显著相关性(Spearman ρ 0.29, < 0.001)。基于血管造影的微循环阻力曲线下面积(AUC)指数为62.2,> 46.5 U被确定为预测IMR bbb25的最佳截止值,为检测冠状动脉微循环功能障碍(CMD)提供38%的敏感性和82%的特异性。结论:S:血管造影微循环阻力指数与有创IMR显著相关;然而,为了提高该方法检测CMD的特异性,应考虑提高截断值。
{"title":"Diagnostic performance of angiography-derived IMR for coronary microcirculation disease assessment in INOCA patients.","authors":"Marta Diachyshyn, Łukasz Niewiara, Piotr Szolc, Paweł Kleczyński, Paulina Judziało, Bartłomiej Guzik, Krzysztof Żmudka, Jacek Legutko","doi":"10.5603/cj.106088","DOIUrl":"https://doi.org/10.5603/cj.106088","url":null,"abstract":"<p><strong>Background: </strong>Diagnosis of coronary microcirculatory dysfunction with wire-based methodology imposes a risk of unplanned revascularization in patients with ischemia and no obstructive coronary arteries (INOCA). Non-invasive, angiography-based methods are introduced to alleviate this risk. The angiography-based index of microcirculatory resistance (IMRangio) is a computational fluid dynamics (CFD)-based index utilizing high-quality angiography and aortic pressures to calculate a surrogate of the index of microcirculatory resistance (IMR).</p><p><strong>Aim of the study: </strong>This study aims to assess the correlation between IMRangio and invasive thermodilution-based IMR in INOCA patients qualified to the MOSAIC-COR registry.</p><p><strong>Methods: </strong>Data from 74 patients (92 coronaries including 52 left anterior descending arteries) from the MOSAIC-COR registry were used for this sub-analysis. All patients had undergone complex coronary physiology assessment using a thermistor-equipped wire and thermodilution-based methodology with subsequent vasomotor acetylcholine vasospasm testing. Post-hoc, CFD-based angiogram analysis was performed to calculate IMRangio values.</p><p><strong>Results: </strong>The median age of patients was 64 years, and 59.3% were female. The median calculated value of IMRangio was 29 (Q1-Q3: 22-46), whereas the invasively measured IMR median value was 17 (Q1-Q3: 13-26). A significant correlation between IMRangio and invasive-IMR was observed (Spearman rho 0.29, < 0.001). Angiography based index of microcirculatory resistance area under the curve (AUC) was 62.2, and a value > 46.5 U was identified as the best cut-off for prediction of IMR > 25 and provided 38% sensitivity and 82% specificity to detect coronary microcirculatory dysfunction (CMD).</p><p><strong>Conclusion: </strong>S: The angiography-based index of microcirculatory resistance significantly correlates with invasively measured IMR; however, a higher cut-off value should be considered to improve the specificity of the method to detect CMD.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145598194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor regarding: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI". 致编辑的信:“P2Y12受体抑制剂对急性冠状动脉综合征患者行PCI的临床结果的影响”。
Pub Date : 2025-11-25 DOI: 10.5603/cj.108667
Julia M Umińska
{"title":"Letter to the Editor regarding: \"The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI\".","authors":"Julia M Umińska","doi":"10.5603/cj.108667","DOIUrl":"https://doi.org/10.5603/cj.108667","url":null,"abstract":"","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145598228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipid-lowering therapy in patients with hypercholesterolemia in terms of the POLSCORE and SCORE2 scales. A single-center retrospective analysis. 根据POLSCORE和SCORE2量表,高胆固醇血症患者的降脂治疗。单中心回顾性分析。
Pub Date : 2025-11-25 DOI: 10.5603/cj.99990
Joanna K Rogozik, Marcin Grabowski, Renata Główczyńska

Background: The global mortality rates due to cardiovascular diseases (CVD) are still alarmingly high, highlighting the need for accurate assessment of the risk of severe cardiovascular (CV) events. To address this, the Pol-SCORE and SCORE2 scales have been developed.

Methods: We conducted an observational and retrospective analysis of 450 patients with LDL ≥ 100 mg/dL admitted to the Clinical Hospital of the Medical University of Warsaw between 2019 and 2020. The objective of our study was to assess the treatment in patients with high levels of LDL cholesterol, without pre-existing CVD, by estimating their CV risk using the Pol-SCORE and SCORE2 scales.

Result: We enrolled a total of 150 patients in the study: 86 women (57.3%) and 64 men (42.7%), with an average age of 55.1 years. The high-risk category in the SCORE2 scale included patients with low, moderate, high, and very high risk estimated in the Pol-SCORE scale. It was statistically significant (p < 0.0001) in the distribution of risk assessment results between groups of CV risk.

Conclusions: According to research, the Pol-SCORE scale has been found to potentially underestimate the likelihood of CV events occurring when compared to the SCORE2 scale, which has a more cautious and restrictive approach. Patients with high and very high risk of fatal and non-fatal CVD are not receiving appropriate treatment. To identify and implement proper recommendations and treatments for patients with elevated risk, the SCORE2 scale should be utilized to estimate CV risk events.

背景:心血管疾病(CVD)的全球死亡率仍然高得惊人,这突出了准确评估严重心血管事件(CV)风险的必要性。为了解决这个问题,我们开发了Pol-SCORE和SCORE2量表。方法:我们对2019年至2020年华沙医科大学临床医院收治的450例LDL≥100 mg/dL患者进行了观察性和回顾性分析。本研究的目的是通过使用Pol-SCORE和SCORE2量表评估无CVD的高水平LDL胆固醇患者的心血管风险,以评估其治疗。结果:共入组150例患者:女性86例(57.3%),男性64例(42.7%),平均年龄55.1岁。SCORE2量表中的高风险类别包括Pol-SCORE量表中估计的低、中、高和极高风险的患者。风险评估结果在CV风险组间分布差异有统计学意义(p < 0.0001)。结论:研究发现,与SCORE2量表相比,Pol-SCORE量表潜在地低估了CV事件发生的可能性,SCORE2量表具有更谨慎和限制性的方法。致死性和非致死性心血管疾病高风险和极高风险的患者没有得到适当的治疗。为了确定并实施对高危患者的适当建议和治疗,应使用SCORE2量表来评估心血管风险事件。
{"title":"Lipid-lowering therapy in patients with hypercholesterolemia in terms of the POLSCORE and SCORE2 scales. A single-center retrospective analysis.","authors":"Joanna K Rogozik, Marcin Grabowski, Renata Główczyńska","doi":"10.5603/cj.99990","DOIUrl":"https://doi.org/10.5603/cj.99990","url":null,"abstract":"<p><strong>Background: </strong>The global mortality rates due to cardiovascular diseases (CVD) are still alarmingly high, highlighting the need for accurate assessment of the risk of severe cardiovascular (CV) events. To address this, the Pol-SCORE and SCORE2 scales have been developed.</p><p><strong>Methods: </strong>We conducted an observational and retrospective analysis of 450 patients with LDL ≥ 100 mg/dL admitted to the Clinical Hospital of the Medical University of Warsaw between 2019 and 2020. The objective of our study was to assess the treatment in patients with high levels of LDL cholesterol, without pre-existing CVD, by estimating their CV risk using the Pol-SCORE and SCORE2 scales.</p><p><strong>Result: </strong>We enrolled a total of 150 patients in the study: 86 women (57.3%) and 64 men (42.7%), with an average age of 55.1 years. The high-risk category in the SCORE2 scale included patients with low, moderate, high, and very high risk estimated in the Pol-SCORE scale. It was statistically significant (p < 0.0001) in the distribution of risk assessment results between groups of CV risk.</p><p><strong>Conclusions: </strong>According to research, the Pol-SCORE scale has been found to potentially underestimate the likelihood of CV events occurring when compared to the SCORE2 scale, which has a more cautious and restrictive approach. Patients with high and very high risk of fatal and non-fatal CVD are not receiving appropriate treatment. To identify and implement proper recommendations and treatments for patients with elevated risk, the SCORE2 scale should be utilized to estimate CV risk events.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145598191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacotherapy in Polish patients with heart failure with reduced ejection fraction - is it optimal? 波兰心力衰竭伴射血分数降低患者的药物治疗是否最佳?
Pub Date : 2025-11-21 DOI: 10.5603/cj.103644
Paula Połaska, Tomasz Urbanik, Hanna Wilk-Manowiec, Radosław Bartkowiak, Iwona Woźniak-Skowerska, Dariusz Nowak, Renata Główczyńska, Jadwiga Nessler, Jacek Gacoń, Leszek Badacz, Grzegorz Drelich, Anna Lisowska, Beata Wożakowska-Kapłon, Lidia Pawłowicz, Anna Kania, Wojciech Sobiczewski, Przemysław Leszek
{"title":"Pharmacotherapy in Polish patients with heart failure with reduced ejection fraction - is it optimal?","authors":"Paula Połaska, Tomasz Urbanik, Hanna Wilk-Manowiec, Radosław Bartkowiak, Iwona Woźniak-Skowerska, Dariusz Nowak, Renata Główczyńska, Jadwiga Nessler, Jacek Gacoń, Leszek Badacz, Grzegorz Drelich, Anna Lisowska, Beata Wożakowska-Kapłon, Lidia Pawłowicz, Anna Kania, Wojciech Sobiczewski, Przemysław Leszek","doi":"10.5603/cj.103644","DOIUrl":"https://doi.org/10.5603/cj.103644","url":null,"abstract":"","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term neurological outcomes after transcatheter aortic valve replacement in high-volume cardiovascular care center. 大容量心血管护理中心经导管主动脉瓣置换术后的长期神经预后。
Pub Date : 2025-11-20 DOI: 10.5603/cj.103252
Szymon Jonik, Alicja Skrobucha, Bartosz Rymuza, Radosław Wilimski, Grzegorz Opolski, Marcin Grabowski, Janusz Kochman, Zenon Huczek

Background: Aortic stenosis (AS) is the most common valvular pathology in Europe and North America, with its prevalence rising due to age-related degeneration and calcification of the aortic valve. The global number of transcatheter aortic valve replacement (TAVR) procedures is rapidly increasing. Nevertheless, the ischemic cerebrovascular events remain among the most significant complications of this procedure. This study aimed to assess the long-term incidence of neurological events and identify the most powerful predictors of stroke following TAVR in a high-volume cardiovascular care center.

Methods: 705 patients who underwent TAVR between January 2016 and September 2022, with a median follow-up of 60 months were analyzed. Baseline patient characteristics, procedural data, and long-term neurological outcomes were evaluated.

Results: At five years the cumulative incidence of any neurological events, strokes and disabling strokes reached 28.5%, 20.3% and 13.2%, respectively. Periprocedural strokes occurred in 1.4% of patients. The multivariable analysis performed was aimed at identifying the relationship between a range of clinical and procedural variables and the incidence of stroke within five years following TAVR.

Conclusions: The findings highlight the importance of long-term neurological follow-up after TAVR, as stroke mechanisms evolve over time - from periprocedural embolization to thrombus formation or chronic conditions like frailty and atherosclerosis. Future research should focus on more targeted stroke prevention and long-term management strategies enhancing safety for the TAVR recipient population.

背景:主动脉瓣狭窄(Aortic stenosis, AS)是欧洲和北美最常见的瓣膜病理,其患病率随着年龄相关的主动脉瓣变性和钙化而上升。经导管主动脉瓣置换术(TAVR)的全球数量正在迅速增加。然而,缺血性脑血管事件仍然是该手术最重要的并发症之一。本研究旨在评估大容量心血管护理中心TAVR术后神经系统事件的长期发生率,并确定最有力的脑卒中预测因素。方法:分析2016年1月至2022年9月期间接受TAVR的705例患者,中位随访时间为60个月。评估基线患者特征、手术数据和长期神经预后。结果:5年神经系统事件、脑卒中和致残性脑卒中的累计发生率分别为28.5%、20.3%和13.2%。术中卒中发生率为1.4%。所进行的多变量分析旨在确定一系列临床和程序变量与TAVR术后5年内卒中发生率之间的关系。结论:研究结果强调了TAVR术后长期神经系统随访的重要性,因为卒中机制随着时间的推移而演变——从术中栓塞到血栓形成或虚弱和动脉粥样硬化等慢性疾病。未来的研究应侧重于更有针对性的卒中预防和长期管理策略,以提高TAVR受体人群的安全性。
{"title":"Long-term neurological outcomes after transcatheter aortic valve replacement in high-volume cardiovascular care center.","authors":"Szymon Jonik, Alicja Skrobucha, Bartosz Rymuza, Radosław Wilimski, Grzegorz Opolski, Marcin Grabowski, Janusz Kochman, Zenon Huczek","doi":"10.5603/cj.103252","DOIUrl":"https://doi.org/10.5603/cj.103252","url":null,"abstract":"<p><strong>Background: </strong>Aortic stenosis (AS) is the most common valvular pathology in Europe and North America, with its prevalence rising due to age-related degeneration and calcification of the aortic valve. The global number of transcatheter aortic valve replacement (TAVR) procedures is rapidly increasing. Nevertheless, the ischemic cerebrovascular events remain among the most significant complications of this procedure. This study aimed to assess the long-term incidence of neurological events and identify the most powerful predictors of stroke following TAVR in a high-volume cardiovascular care center.</p><p><strong>Methods: </strong>705 patients who underwent TAVR between January 2016 and September 2022, with a median follow-up of 60 months were analyzed. Baseline patient characteristics, procedural data, and long-term neurological outcomes were evaluated.</p><p><strong>Results: </strong>At five years the cumulative incidence of any neurological events, strokes and disabling strokes reached 28.5%, 20.3% and 13.2%, respectively. Periprocedural strokes occurred in 1.4% of patients. The multivariable analysis performed was aimed at identifying the relationship between a range of clinical and procedural variables and the incidence of stroke within five years following TAVR.</p><p><strong>Conclusions: </strong>The findings highlight the importance of long-term neurological follow-up after TAVR, as stroke mechanisms evolve over time - from periprocedural embolization to thrombus formation or chronic conditions like frailty and atherosclerosis. Future research should focus on more targeted stroke prevention and long-term management strategies enhancing safety for the TAVR recipient population.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron deficiency and nutritional status in heart failure with reduced ejection fraction: a cross-sectional study. 心力衰竭伴射血分数降低的缺铁和营养状况:一项横断面研究。
Pub Date : 2025-11-20 DOI: 10.5603/cj.103272
Marta Kałużna-Oleksy, Filip Sawczak, Aleksandra Soloch, Maria Cierzniak, Alicja Szubarga, Agata Kukfisz, Helena Krysztofiak, Magdalena Dudek, Michał Hawranek, Ewa Straburzyńska-Migaj

Background: Iron deficiency (ID) impacts prognosis and quality of life for heart failure (HF) patients. It is essential to actively search for ID in this group and establish its relationship with nutritional status. The aim was to determine the relationship between nutritional status according to the Mini Nutritional Assessment (MNA) questionnaire and the presence of ID in heart failure patients with reduced ejection fraction (HFrEF).

Methods: The study sample comprized 272 HFrEF patients. Collected on admission were: medical history, echocardiographic and biochemical parameters. Iron deficiency was diagnosed if ferritin was < 100 ng/mL or < 300 ng/mL with transferrin saturation (TSAT) < 20%. Nutritional status was assessed using the MNA form and body mass index (BMI).

Results: The cohort was 81.6% male and 18.4% female. The median age was 59 (IQR 50-64) years, and the mean BMI was 28.8 ± 5.3 kg/m². 54.4% of patients showed New York Heart Association (NYHA) class III or IV HF symptoms. Iron deficiency was detected in 55.5% of patients. Participants at risk of malnutrition constituted 45.2%, while 1.8% were malnourished. In the ID group 45% were at risk of malnutrition and 2.6% were malnourished, compared with 45.4% (p = 1.00) and 0.8% (p = 0.39) in the no-ID group. Female sex and atrial fibrillation(AF) were associated with ID.

Conclusions: Nutritional status assessed by the MNA questionnaire is not related to the presence of ID in HFrEF. Female sex and AF are risk factors for ID in this group.

背景:缺铁(ID)影响心力衰竭(HF)患者的预后和生活质量。在这一群体中积极寻找ID,建立其与营养状况的关系是十分必要的。目的是确定根据迷你营养评估(MNA)问卷的营养状况与低射血分数(HFrEF)心力衰竭患者ID的存在之间的关系。方法:研究样本包括272例HFrEF患者。入院时收集的资料有:病史、超声心动图及生化指标。铁蛋白< 100ng /mL或< 300ng /mL,转铁蛋白饱和度(TSAT) < 20%,诊断为缺铁。营养状况评估采用MNA表格和身体质量指数(BMI)。结果:队列中男性占81.6%,女性占18.4%。中位年龄59岁(IQR 50 ~ 64岁),平均BMI 28.8±5.3 kg/m²。54.4%的患者出现纽约心脏协会(NYHA) III级或IV级HF症状。55.5%的患者缺铁。有营养不良风险的参与者占45.2%,而1.8%的人营养不良。ID组有营养不良风险的比例为45%,营养不良的比例为2.6%,而无ID组分别为45.4% (p = 1.00)和0.8% (p = 0.39)。女性和房颤(AF)与ID相关。结论:MNA问卷评估的营养状况与HFrEF中ID的存在无关。女性性别和房颤是这一群体发生ID的危险因素。
{"title":"Iron deficiency and nutritional status in heart failure with reduced ejection fraction: a cross-sectional study.","authors":"Marta Kałużna-Oleksy, Filip Sawczak, Aleksandra Soloch, Maria Cierzniak, Alicja Szubarga, Agata Kukfisz, Helena Krysztofiak, Magdalena Dudek, Michał Hawranek, Ewa Straburzyńska-Migaj","doi":"10.5603/cj.103272","DOIUrl":"https://doi.org/10.5603/cj.103272","url":null,"abstract":"<p><strong>Background: </strong>Iron deficiency (ID) impacts prognosis and quality of life for heart failure (HF) patients. It is essential to actively search for ID in this group and establish its relationship with nutritional status. The aim was to determine the relationship between nutritional status according to the Mini Nutritional Assessment (MNA) questionnaire and the presence of ID in heart failure patients with reduced ejection fraction (HFrEF).</p><p><strong>Methods: </strong>The study sample comprized 272 HFrEF patients. Collected on admission were: medical history, echocardiographic and biochemical parameters. Iron deficiency was diagnosed if ferritin was < 100 ng/mL or < 300 ng/mL with transferrin saturation (TSAT) < 20%. Nutritional status was assessed using the MNA form and body mass index (BMI).</p><p><strong>Results: </strong>The cohort was 81.6% male and 18.4% female. The median age was 59 (IQR 50-64) years, and the mean BMI was 28.8 ± 5.3 kg/m². 54.4% of patients showed New York Heart Association (NYHA) class III or IV HF symptoms. Iron deficiency was detected in 55.5% of patients. Participants at risk of malnutrition constituted 45.2%, while 1.8% were malnourished. In the ID group 45% were at risk of malnutrition and 2.6% were malnourished, compared with 45.4% (p = 1.00) and 0.8% (p = 0.39) in the no-ID group. Female sex and atrial fibrillation(AF) were associated with ID.</p><p><strong>Conclusions: </strong>Nutritional status assessed by the MNA questionnaire is not related to the presence of ID in HFrEF. Female sex and AF are risk factors for ID in this group.</p>","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concomitant Impella 5.5 with venoarterial extracorporeal membrane oxygenation via modified single arterial access technique using buried Y-graft. 通过改良单动脉通道技术,采用埋置y型移植物,伴行Impella 5.5静脉-动脉体外膜氧合。
Pub Date : 2025-11-19 DOI: 10.5603/cj.108035
Kaung Sithu Sett, Maciej Bochenek, Maciej Rachwalik
{"title":"Concomitant Impella 5.5 with venoarterial extracorporeal membrane oxygenation via modified single arterial access technique using buried Y-graft.","authors":"Kaung Sithu Sett, Maciej Bochenek, Maciej Rachwalik","doi":"10.5603/cj.108035","DOIUrl":"https://doi.org/10.5603/cj.108035","url":null,"abstract":"","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145552180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiology journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1